Impact of smoking in patients undergoing transcatheter aortic valve replacement.

Publication/Presentation Date

1-1-2018

Abstract

Background: The paradox that smokers have better clinical outcomes in cardiovascular diseases remains controversial. No literature exists studying impact of smoking on outcomes following transcatheter aortic valve replacement (TAVR).

Methods: We performed an electronic search of the 2011-2012 National Inpatient Sample (NIS) database to identify all TAVR hospitalizations. Outcomes were measured comparing smokers to non-smokers.

Results: A total of 8,345 TAVR hospitalizations were identified with 24% being smokers. Compared to non-smokers, smokers were younger (80.4±8.8 vs. 81.4±9.2 years, P

Conclusions: Despite having a higher cardiovascular disease burden, smokers had better outcomes compared to non-smokers. Therefore the smoker's paradox is applicable in the TAVR cohort.

Volume

6

Issue

1

First Page

2

Last Page

2

ISSN

2305-5839

Disciplines

Cardiology | Medical Sciences | Medicine and Health Sciences

PubMedID

29404348

Department(s)

Department of Medicine, Cardiology Division, Department of Medicine Fellows and Residents

Document Type

Article

Link to Full Text

Share

COinS